Apyx Medical Corporation Submits FDA 510 (k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction - Apyx Medical (NASDAQ:APYX)
Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025
How this was made

The 30-second read
Why it matters
Successful FDA submission and upcoming launch could serve as catalysts for stock appreciation, but regulatory hurdles remain a risk.
Market read
The news is highly relevant for investors interested in medical device innovation and aesthetic surgery markets.
What to watch
Market sentiment may already be priced in; broader industry or macroeconomic factors could overshadow company-specific news.
Background
Apyx Medical is advancing its AYON Body Contouring System™ through FDA clearance processes, aiming to expand its product labeling for Power Liposuction applications.
Ticker impact
The news pertains directly to Apyx Medical Corporation's FDA submission and product launch activities, indicating high relevance for the company's stock.
Moderate upward movement in the short term, with potential for sustained growth if FDA approval is granted and launch proceeds smoothly.
Regulatory approvals and product launches are significant events that can positively influence stock performance, especially when supported by upcoming commercial activities.
Market effects
Potential uplift in medical device and aesthetic surgery sectors due to new product approval and launch
Primarily US-focused, with possible international interest following FDA clearance
Moderate, depending on international regulatory pathways and adoption
Counterpoint
Regulatory delays or adverse clinical feedback could postpone or hinder product launch, negatively impacting stock performance.
Key entities
- CompanyApyx Medical Corporation
Developer of medical devices, including aesthetic and surgical products.
- ProductAYON Body Contouring System™
A device used for body contouring and liposuction procedures.


